A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

PubWeight™: 16.00‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMID 7622868)

Published in J Immunol Methods on July 17, 1995

Authors

I Vermes1, C Haanen, H Steffens-Nakken, C Reutelingsperger

Author Affiliations

1: Department of Clinical Chemistry, Medical Spectrum Twente, Enschede, Netherlands.

Articles citing this

(truncated to the top 100)

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest (2008) 6.15

Induction of autophagy by spermidine promotes longevity. Nat Cell Biol (2009) 5.00

RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J (1996) 4.33

Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A (2010) 3.58

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest (1997) 3.22

Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol (2001) 3.17

Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev (1999) 3.04

Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med (1998) 3.01

Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc Natl Acad Sci U S A (2000) 2.99

Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med (2000) 2.91

A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol (2005) 2.77

Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun (2000) 2.70

Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med (1998) 2.69

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med (2000) 2.57

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol (1998) 2.49

Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48

Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev (2000) 2.47

Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology (2014) 2.30

Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity. Genes Dev (2008) 2.27

Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J Exp Med (1997) 2.21

Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging (2004) 2.21

Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death. PLoS Pathog (2009) 2.19

Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci U S A (2004) 2.18

Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood (2006) 2.16

Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum (2002) 2.08

Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med (2004) 2.05

Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest (2001) 2.00

Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med (2000) 1.98

NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol (2007) 1.94

Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci U S A (1999) 1.94

Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A (2004) 1.90

Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest (1997) 1.89

The invasive chytrid fungus of amphibians paralyzes lymphocyte responses. Science (2013) 1.88

Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J Immunol (1999) 1.88

Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol (2001) 1.87

T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest (2000) 1.85

A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol (1999) 1.84

Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J Clin Invest (2007) 1.80

The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J Exp Med (1997) 1.79

Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage. J Exp Med (2008) 1.79

Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J Virol (2007) 1.75

A practical guide to rodent islet isolation and assessment. Biol Proced Online (2009) 1.74

In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res (2007) 1.71

Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. EMBO J (1999) 1.71

Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog (2010) 1.67

The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med (2003) 1.64

The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest (2002) 1.63

Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother (2004) 1.63

Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest (1999) 1.62

Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut (1998) 1.61

Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol (1998) 1.61

A protective role for inflammasome activation following injury. Shock (2012) 1.60

Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J Clin Invest (2009) 1.58

Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production. J Exp Med (2000) 1.57

Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med (1996) 1.56

Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One (2010) 1.56

Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection. Gut (1999) 1.55

Prolylcarboxypeptidase promotes angiogenesis and vascular repair. Blood (2013) 1.54

CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol (1997) 1.51

Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages. Proc Natl Acad Sci U S A (2001) 1.51

Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Cell Death Differ (2000) 1.49

Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials. PLoS One (2008) 1.49

Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol Cell Biol (2004) 1.48

Necrosis of lung epithelial cells during infection with Mycobacterium tuberculosis is preceded by cell permeation. Infect Immun (2000) 1.48

Brain abnormalities, defective meiotic chromosome synapsis and female subfertility in HSF2 null mice. EMBO J (2002) 1.48

Parachlamydia acanthamoebae enters and multiplies within human macrophages and induces their apoptosis [corrected]. Infect Immun (2003) 1.47

Heat shock protein 90 positively regulates Chikungunya virus replication by stabilizing viral non-structural protein nsP2 during infection. PLoS One (2014) 1.45

Human Mcm10 regulates the catalytic subunit of DNA polymerase-alpha and prevents DNA damage during replication. Mol Biol Cell (2007) 1.44

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci U S A (2003) 1.42

Biologic effects induced in vitro by PM10 from three different zones of Mexico City. Environ Health Perspect (2002) 1.41

PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest (2009) 1.41

Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. Infect Immun (2000) 1.41

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma. J Natl Cancer Inst (2016) 1.40

Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells. Elife (2017) 1.39

Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J Immunol (2002) 1.39

A novel apoptosis-inducing monoclonal antibody (anti-LHK) against a cell surface antigen on colon cancer cells. J Gastroenterol (2005) 1.39

Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood (2006) 1.38

A central role for thymic emigrants in peripheral T cell homeostasis. Proc Natl Acad Sci U S A (1999) 1.37

Inhibition of the mammalian transcription factor LSF induces S-phase-dependent apoptosis by downregulating thymidylate synthase expression. EMBO J (2000) 1.36

Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect Immun (2007) 1.36

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J Clin Invest (1998) 1.36

Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology (1998) 1.34

Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling. Neuron (2011) 1.34

Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia (2011) 1.34

Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB. Mol Cell Biol (1999) 1.33

Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res (2003) 1.32

Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function. J Transl Med (2011) 1.31

Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol (2010) 1.31

Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells. Immunology (2003) 1.30

Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation. J Virol (2001) 1.29

Structural simplification of bioactive natural products with multicomponent synthesis. 2. antiproliferative and antitubulin activities of pyrano[3,2-c]pyridones and pyrano[3,2-c]quinolones. J Med Chem (2008) 1.28

Hsp60 is actively secreted by human tumor cells. PLoS One (2010) 1.27

Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53. Br J Cancer (2009) 1.26

Deficient in vitro and in vivo phagocytosis of apoptotic T cells by resident murine alveolar macrophages. J Immunol (2000) 1.25

Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. Br J Cancer (1997) 1.23

Rodent anterior ischemic optic neuropathy (rAION) induces regional retinal ganglion cell apoptosis with a unique temporal pattern. Invest Ophthalmol Vis Sci (2008) 1.23

Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Med (2009) 1.23

Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival. Am J Physiol Heart Circ Physiol (2006) 1.22

Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth. J Natl Cancer Inst (2008) 1.22

A single E627K mutation in the PB2 protein of H9N2 avian influenza virus increases virulence by inducing higher glucocorticoids (GCs) level. PLoS One (2012) 1.21

Articles by these authors

Flow cytometry of apoptotic cell death. J Immunol Methods (2000) 2.30

Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. J Clin Oncol (1989) 2.12

Malaria: phosphatidylserine expression is not increased on the surface of parasitized erythrocytes. Parasitol Today (1995) 2.05

Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab (1995) 2.03

Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet (1999) 1.63

Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells. Exp Hematol (1991) 1.41

Clinical course in 28 unselected patients with aplastic anaemia treated with anabolic steroids. Br J Haematol (1979) 1.39

Clinical pharmacokinetics of doxorubicin. Clin Pharmacokinet (1988) 1.37

Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab (2001) 1.18

In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia (1993) 1.09

A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp Hematol (1980) 1.09

Apoptosis and programmed cell death in health and disease. Adv Clin Chem (1994) 1.04

Clinical course and survival in 16 patients with localized plasmacytoma. Scand J Haematol (1984) 1.02

Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used. Apoptosis (2004) 1.01

A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother (1985) 1.01

Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood (1982) 0.98

The effect of lithium on platelet aggregation and platelet release reaction. Thromb Res (1977) 0.96

Hageman factor, a novel sialoglycoprotein with esterase activity. Biochim Biophys Acta (1965) 0.96

Early features of apoptosis detected by four different flow cytometry assays. Apoptosis (1998) 0.94

Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients. Cancer Chemother Pharmacol (1987) 0.94

A simple test for measuring platelet aggregation. Results in von Willebrand's disease and uraemia. Thromb Diath Haemorrh (1969) 0.94

Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry. Blood (1992) 0.92

Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells. Exp Cell Res (1988) 0.91

The immunoglobulins in Hodgkin's disease. Eur J Cancer (1976) 0.91

Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia. Clin Pharmacol Ther (1977) 0.91

Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci (1997) 0.91

Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chemother Pharmacol (1987) 0.90

Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973). Blood (1975) 0.90

Clinical course and survival after elective splenectomy in 19 patients with primary myelofibrosis. Br J Haematol (1977) 0.89

Monocyte purification with counterflow centrifugation monitored by continuous flow cytometry. J Immunol Methods (1981) 0.88

Familial thrombopathic thrombocytopenia. Br J Haematol (1968) 0.88

Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer. Cytometry (1990) 0.88

Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol (1997) 0.87

Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent. Thromb Diath Haemorrh (1967) 0.87

Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. Bone Marrow Transplant (1994) 0.87

Platelet function and von Willebrand's disease. Lancet (1968) 0.86

Simplified method for DNA and protein staining of human hematopoietic cell samples. Cytometry (1981) 0.85

Cytosine arabinoside binding to human plasma proteins. Arch Int Pharmacodyn Ther (1977) 0.85

Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol (1998) 0.85

Blastomycosis treated successfully with miconazole. Trop Geogr Med (1979) 0.85

Observations on platelet ultrastructure in familial thrombocytopathic thrombocytopenia. Am J Pathol (1968) 0.84

Annexin V labels apoptotic neurons following hypoxia-ischemia. Neuroreport (1997) 0.84

Chronic lymphocytic leukaemia presenting as renal failure with lymphocytic infiltration of the kidneys. Neth J Med (1992) 0.84

Rapid quantitative determination of four anthracyclines and their main metabolites in human nucleated haematopoietic cells. J Chromatogr (1986) 0.83

Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography. Cytometry (1985) 0.83

Significance of fibrin split products in patients with renal failure. Scand J Haematol Suppl (1971) 0.82

Different susceptibilities of normal T cells and T cell lines to immunotoxins. Scand J Immunol (1988) 0.82

Endogenous mediators in sepsis and septic shock. Adv Clin Chem (1998) 0.81

Preparation and clinical use of factor IX concentrate PPSB according to Soulier. Vox Sang (1969) 0.81

Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Blood (1989) 0.81

Bone-marrow-profileration patterns in acute myeloblastic leukaemia determined by pulse cytophotometry. Lancet (1975) 0.81

Combined immunodeficiency preceding chronic lymphocytic leukemia. Blut (1984) 0.80

Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation. Transplantation (1984) 0.80

Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma. Cancer Chemother Pharmacol (1986) 0.80

Hormonal dependent thrombotic thrombocytopenic purpura (TTP). Scand J Haematol (1983) 0.80

"Incubation period" in Hodgkin's disease. Lancet (1975) 0.80

Sequential occurrence of mitochondrial and plasma membrane alterations, fluctuations in cellular Ca2+ and pH during initial and later phases of cell death. Apoptosis (1999) 0.80

Studies on a new radiopaque polymeric biomaterial. Biomaterials (1994) 0.80

A hereditary abnormal c-fms proto-oncogene in a patient with acute lymphocytic leukaemia and congenital hypothyroidism. Br J Haematol (1985) 0.79

Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's disease. Eur J Cancer Clin Oncol (1983) 0.79

In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells. Eur J Cancer Clin Oncol (1988) 0.79

A new multichamber counterflow centrifugation rotor with high-separation capacity and versatile potentials. Exp Hematol (1988) 0.79

Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Blood (1992) 0.79

Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion. Clin Pharmacol Ther (1987) 0.79

Treatment of Pseudomonas aeruginosa septicemia in neutropenic patients with ceftazidime. Eur J Clin Microbiol (1985) 0.78

Activation of prothrombin in the presence of human umbilical-vein endothelial cells. Biochem J (1992) 0.78

Intravascular clotting and acute renal failure. Scand J Haematol Suppl (1971) 0.78

Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. Blood (1986) 0.78

In vitro effects of estradiol, dydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells. Cancer Lett (2003) 0.78

Visualisation of cell death. Lancet (2000) 0.78

Flow cytometric determination of the S-phase compartment in adult acute leukemia. Acta Haematol (1983) 0.78

Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease. Eur J Clin Invest (1977) 0.78

Peripheral blood cell harvests yield primitive multilineage progenitor cells in the CD34+/33- fraction. Int J Artif Organs (1993) 0.78

Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity. Scand J Immunol (1988) 0.78

Influence of lithium on aggregation, release-reaction and function of human platelets. Pathol Biol (Paris) (1972) 0.78

Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia. Semin Oncol (1985) 0.78

Drug-induced skin reactions in patients with acute non-lymphocytic leukaemia. Eur J Haematol (1987) 0.78

Studies on the cytotoxicity of cytosine arabinoside. Semin Oncol (1985) 0.78

Increased antibody-dependent cytotoxicity mediated by purified monocytes in Hodgkin's disease. Clin Immunol Immunopathol (1983) 0.77

Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group. Blood (1989) 0.77

In-vitro studies on phosphorylation and dephosphorylation of cytosine arabinoside in human leukemic cells. Leuk Res (1987) 0.77

Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state. Leukemia (1994) 0.77

DNA strand breaks in human leukocytes induced by chemotherapy and total body irradiation. Leuk Res (1990) 0.77

Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recovery. Bone Marrow Transplant (1989) 0.77

Lithium stimulates thromboxane B2 formation in human platelets. Prostaglandins Med (1981) 0.77

Mathematical correlation between ADP-induced platelet aggregation and subsequent disaggregation. A parameter for the velocity of disaggregation. Scand J Haematol (1969) 0.77

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer (1990) 0.77

The effect of cytosine arabinoside upon mitochondrial staining kinetics in human hematopoietic cells. Histochemistry (1986) 0.77

The relation of exposure time and drug concentration in their effect on cloning efficiency after incubation of human bone marrow with cytosine arabinoside. Br J Haematol (1986) 0.77

E-rosette positive acute lymphoblastic leukaemia in adolescents and adults. Br J Haematol (1983) 0.77

Separation of human bone marrow by counterflow centrifugation monitored by DNA-flowcytometry. Br J Haematol (1984) 0.77

Ex vivo evidence of lymphocyte apoptosis in hairy cell leukemia, induced by 2-chlorodeoxyadenosine treatment. Ann Hematol (1998) 0.77

A comparative study concerning the stability of the anticoagulant effect of acenocoumarol and phenprocoumon. Acta Med Scand (1969) 0.76

Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin. Anticancer Res (1993) 0.76

Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause. Mov Disord (1999) 0.76

Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics. Ann Hematol (1993) 0.76